Disease Groups Beg Congress For Antibiotics R&D Boost
A coalition of 50 public health groups has sent letters to congressional leaders urging them to include incentives for new antibiotic research and development in the Prescription Drug User Fee Act...To view the full article, register now.
Already a subscriber? Click here to view full article